News Releases

Aspirin use appears to reduce the risk of Barrett's esophagus, the largest known risk factor for esophageal cancer.

Aspirin protects against Barrett's esophagus

23/Jul/2012

Aspirin use appears to reduce the risk of Barrett's esophagus, the largest known risk factor for esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

"The protective effect of aspirin use appears robust because the analyses suggests a dose-response relationship in which high-dose aspirin was significantly associated with decreased Barrett's esophagus risk," said Chin Hur, MD, MPH, of the Massachusetts General Hospital Institute for Technology Assessment and lead author of this study.

Link to full American Gastroenterological Association release.

patient

#4 in the nation for digestive care

U.S. News & World Report ranks Mass General gastroenterology fourth among U.S. hospitals.